Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (11-20 of 720) with videos related to

Pageof 72
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 4, 2019
A Conversation Between Stefano Buono and Ken HerrmannStefano Buono, Ken Herrmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2020
A Conversation Between Ignasi Carrió and Ken HerrmannIgnasi Carrió, Ken Herrmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 19, 2016
From NETTER to PETTER: PSMA-Targeted Radioligand TherapyMatthias Eiber, Ken Herrmann
European Urology|January 30, 2026
Reply to Armando Stabile, Giorgio Gandaglia, Arturo Chiti, and Francesco Montorsi's Letter to the Editor re: Ken Herrmann, Jochen Walz, Steven MacLennan, et al. SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.08.005Ken Herrmann, Louise Emmett,
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 22, 2026
From Anatomy to Theranostics: Toni Choueiri Talks with Ken Herrmann About the Evolution of Genitourinary OncologyToni K Choueiri, Ken Herrmann
European Urology|April 16, 2026
Considerations for Earlier Use of Radiopharmaceutical Therapy in Prostate CancerMarc B Garnick, Ken Herrmann,
PET Clinics|May 10, 2016
Therapy Monitoring with Fluorine-18 FDG-PET and Fluorine-18 FDG-PET/CTHinrich A Wieder, Ken Herrmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 2020
Real-World Data as an Evidence Source in Nuclear MedicineAriel B Bourla, Ken Herrmann
Nuklearmedizin. Nuclear Medicine|August 15, 2019
[Future Workshop 1.0 - Departure into the future or a flash in the pan?]Ken Herrmann, Lutz S Freudenberg
PET Clinics|July 18, 2014
Proliferation imaging with ¹⁸F-fluorothymidine PET/computed tomography: physiologic uptake, variants, and pitfallsKen Herrmann, Andreas K Buck
Pageof 72

Showing results (11-20 of 720) with videos related to

Sort By:
Pageof 72
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 4, 2019
A Conversation Between Stefano Buono and Ken HerrmannStefano Buono, Ken Herrmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2020
A Conversation Between Ignasi Carrió and Ken HerrmannIgnasi Carrió, Ken Herrmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 19, 2016
From NETTER to PETTER: PSMA-Targeted Radioligand TherapyMatthias Eiber, Ken Herrmann
European Urology|January 30, 2026
Reply to Armando Stabile, Giorgio Gandaglia, Arturo Chiti, and Francesco Montorsi's Letter to the Editor re: Ken Herrmann, Jochen Walz, Steven MacLennan, et al. SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.08.005Ken Herrmann, Louise Emmett,
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 22, 2026
From Anatomy to Theranostics: Toni Choueiri Talks with Ken Herrmann About the Evolution of Genitourinary OncologyToni K Choueiri, Ken Herrmann
European Urology|April 16, 2026
Considerations for Earlier Use of Radiopharmaceutical Therapy in Prostate CancerMarc B Garnick, Ken Herrmann,
PET Clinics|May 10, 2016
Therapy Monitoring with Fluorine-18 FDG-PET and Fluorine-18 FDG-PET/CTHinrich A Wieder, Ken Herrmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 2020
Real-World Data as an Evidence Source in Nuclear MedicineAriel B Bourla, Ken Herrmann
Nuklearmedizin. Nuclear Medicine|August 15, 2019
[Future Workshop 1.0 - Departure into the future or a flash in the pan?]Ken Herrmann, Lutz S Freudenberg
PET Clinics|July 18, 2014
Proliferation imaging with ¹⁸F-fluorothymidine PET/computed tomography: physiologic uptake, variants, and pitfallsKen Herrmann, Andreas K Buck
Pageof 72